LRG1 is known to be a biomarker for various inflammatory diseases, including rheumatoid arthritis, ulcerative colitis, and asthma [31–33], and also functions as an endothelial cell mitogen for tumor and retinal neovascularization [34, 35]. This evidence concerns the gene LRG1 and rheumatoid arthritis.